Phase 1 dose-escalation study of 17-allylamino-17-demethoxygeldanamycin (17AAG) in combination with irinotecan in patients with solid tumors Meeting Abstract

  


Authors: Tse, A. N.; Carvajal, R.; Shah, M.; Dials, H.; Fogel, M.; O'Reilly, E.; Chung, K.; Maki, R.; Wu, N.; Egorin, M.; Schwartz, G. K.
Abstract Title: Phase 1 dose-escalation study of 17-allylamino-17-demethoxygeldanamycin (17AAG) in combination with irinotecan in patients with solid tumors
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 146s
Language: English
ACCESSION: WOS:000455043700586
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.3533
Notes: Meeting Abstract: 3533 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Ki Y Chung
    43 Chung
  3. Archie Tse
    34 Tse
  4. Richard D Carvajal
    148 Carvajal
  5. Robert Maki
    238 Maki
  6. Manish Shah
    177 Shah
  7. Nian Wu
    32 Wu
  8. Eileen O'Reilly
    780 O'Reilly
Related MSK Work